In this context, IL8-induced UPK1A-AS1 functions as a key factor in the crosstalk between CAFs and cancer cells, supporting the urgent need for the development of rational strategies that target the IL8/UPK1A-AS1 axis to overcome platinum resistance in pancreatic cancer patients. This evidence concerns the gene UPK1A and pancreatic neoplasm.